In December 2025, a federal panel combined 21 Ozempic and related GLP-1 vision loss lawsuits into a multidistrict litigation (MDL) in the Eastern District of Pennsylvania
The pivotal SURPASS clinical trial programme, which evaluated tirzepatide's efficacy and safety, did not identify night sweats as a frequent or significant adverse event
[DOI] [PubMed] [Google Scholar] Wang X, Zhou J, Doyle ME, Egan JM
[11] [16] Los efectos secundarios de la semaglutida son predominantemente gastrointestinales, especialmente durante las primeras semanas de tratamiento o cuando se aumenta la dosis
Some of our patients may require injections as early as adolescence, while others may not need them until much later in life
Can I switch to Tirzepatide if Semaglutide stops working for me